InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the detailed record of transactions filed by Dash Barry H, Director. Officer active across 1 company, notably Elite Pharmaceuticals INC. Cumulatively, 4 disclosures have been published. Activity tracked since 30 June 2021. The latest transaction was filed on 22 November 2023 (Attribution). Regulator: SEC (Form 4). All data is free.
4 of 4 declarations
Barry H. Dash is a Board Member at Elite Pharmaceuticals Inc. He plays a key role in overseeing the company's operations and strategic decision-making. With experience in the pharmaceutical sector, he contributes to the strategic direction of Elite Pharmaceuticals, which focuses on developing generic drugs.